comparemela.com
Home
Live Updates
Tirofiban a Better Option for Ischemic Stroke When Lytics an
Tirofiban a Better Option for Ischemic Stroke When Lytics an
Tirofiban a Better Option for Ischemic Stroke When Lytics and Thrombectomy Aren't?
TREND trial compares acute antiplatelet monotherapies
Related Keywords
Xuanwu ,
Henan ,
China ,
Beijing ,
United States ,
Phoenix ,
Arizona ,
Chinese ,
American ,
Larryb Goldstein ,
Wenbo Zhao ,
American Stroke Association International Conference ,
International Stroke Conference ,
Xuanwu Hospital At Capital Medical University ,
University Of Kentucky ,
Xuanwu Hospital ,
Capital Medical University ,
American Stroke Association ,
International Stroke ,
New England Journal ,
Rankin Scale ,